Literature DB >> 28889023

Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy.

Liqian Sun1, Manman Zhao2, Man Liu2, Peng Su2, Jingbo Zhang3, Youxiang Li3, Xinjian Yang3, Zhongxue Wu3.   

Abstract

Traumatic brain injury (TBI) is a serious insult that frequently leads to neurological impairments. Forkhead box O (FoxO) 3a, as transcription factor, has been confirmed to modulate autophagic process. Moreover, FoxO3a is expressed throughout the brain including the hippocampus. However, the role of FoxO3a in the pathophysiology of TBI is unclear. The present study is designed to investigate whether FoxO3a has the neuroprotective effects on rats subjected to TBI, and further to explore the potential molecular mechanisms. Thus, a rat model of TBI was created by using a modified weight-drop device to mimic the insults of TBI. The results showed that FoxO3a was significantly increased in the serum of patients with TBI as well as in experimental animals. Furthermore, our data also demonstrated that TBI stimulated the translocation of FoxO3a from the cytosol to the nucleus. Additionally, we found that knockdown of FoxO3a by siRNA silencing significantly improved neurobehavioral dysfunctions and conferred a better neuroprotective effects after TBI, evidenced by promoting motor behavioral recovery, attenuating learning and memory impairments, and partially reversing neuronal damage in the hippocampus. To further investigate the molecular mechanisms underlying this neuroprotection, we identified that nuclear accumulation of Foxo3a could induce highly expression of autophagy pathway genes including LC-3, Beclin-1, p62, ATG12, and ATG14, and finally initiate neurological impairments. Interestingly, silencing FoxO3a by siRNA remarkably inhibited the induction of neuronal autophagy after TBI, and activated autophagy was closely related to TBI-induced neurological deficits. Taken together, these findings indicated that FoxO3a knockdown conferred neuroprotective effects after TBI through inhibiting the activation of neuronal autophagy.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Autophagy; FoxO3a; Neurobehavioral deficits; Neuron; Traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 28889023     DOI: 10.1016/j.bbr.2017.08.042

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  10 in total

Review 1.  Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target.

Authors:  Ehsan Dadgostar; Shiva Rahimi; Shahin Nikmanzar; Sina Nazemi; Mojtaba Naderi Taheri; Zahra Alibolandi; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurochem Res       Date:  2022-01-28       Impact factor: 3.996

Review 2.  An Overview of the Perspective of Cellular Autophagy: Mechanism, Regulation, and the Role of Autophagy Dysregulation in the Pathogenesis of Diseases.

Authors:  Yasser M Alharbi; Abdulhadi I Bima; Ayman Z Elsamanoudy
Journal:  J Microsc Ultrastruct       Date:  2021-01-09

3.  Multi-Dimensional Mapping of Brain-Derived Extracellular Vesicle MicroRNA Biomarker for Traumatic Brain Injury Diagnostics.

Authors:  Jina Ko; Matthew Hemphill; Zijian Yang; Kryshawna Beard; Emily Sewell; Jamie Shallcross; Melissa Schweizer; Danielle K Sandsmark; Ramon Diaz-Arrastia; Junhyong Kim; David Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2019-05-06       Impact factor: 4.869

Review 4.  Autophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention.

Authors:  Li Zhang; Handong Wang
Journal:  Front Mol Neurosci       Date:  2018-06-05       Impact factor: 5.639

Review 5.  Autophagy in Age-Associated Neurodegeneration.

Authors:  Athanasios Metaxakis; Christina Ploumi; Nektarios Tavernarakis
Journal:  Cells       Date:  2018-05-05       Impact factor: 6.600

6.  miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1.

Authors:  Guojian Liu; Xiaowen Kang; Ping Guo; Yu Shang; Ruomei Du; Xiyue Wang; Liting Chen; Rui Yue; Fanwu Kong
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 7.  Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia.

Authors:  Feixue Wang; Yu Cao; Lina Ma; Hui Pei; Wolf Dieter Rausch; Hao Li
Journal:  Front Aging Neurosci       Date:  2018-11-16       Impact factor: 5.750

8.  A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.

Authors:  Stefan Salcher; Gilles Spoden; Judith Hagenbuchner; Sebastian Führer; Teresa Kaserer; Martin Tollinger; Petra Huber-Cantonati; Thomas Gruber; Daniela Schuster; Ronald Gust; Heinz Zwierzina; Thomas Müller; Ursula Kiechl-Kohlendorfer; Michael J Ausserlechner; Petra Obexer
Journal:  Oncogene       Date:  2019-10-07       Impact factor: 9.867

9.  FoxO3a suppresses neuropeptide W expression in neuronal cells and in rat hypothalamus and its implication in hypothalamic-pituitary-adrenal (HPA) axis.

Authors:  Fengxia Yan; Rikang Wang; Shuai Li; Xia Zhao; Yizhou Jiang; Linlin Liu; Jiankang Fang; Xuechu Zhen; Philip Lazarovici; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2020-08-25       Impact factor: 6.580

10.  Deletion of MicroRNA-144/451 Cluster Aggravated Brain Injury in Intracerebral Hemorrhage Mice by Targeting 14-3-3ζ.

Authors:  Xiaohong Wang; Yin Hong; Lei Wu; Xiaochun Duan; Yue Hu; Yongan Sun; Yanqiu Wei; Zhen Dong; Chenghao Wu; Duonan Yu; Jun Xu
Journal:  Front Neurol       Date:  2021-01-12       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.